The interaction of miRNA and lncRNA is known to be important for gene regulations. However, the number of known lncRNA-miRNA interactions is still very limited and there are limited computational tools available for predicting new ones. Considering that lncRNAs and miRNAs share internal patterns in the partnership between each other, the underlying lncRNA-miRNA interactions could be predicted by utilizing the known ones, which could be considered as a semi-supervised learning problem. It is shown that the attributes of lncRNA and miRNA have a close relationship with the interaction between each other. Effective use of side information could be helpful for improving the performance especially when the training samples are limited. In view of this, we proposed an end-to-end prediction model called GCLMI (Graph Convolution for novel lncRNA-miRNA Interactions) by combining the techniques of graph convolution and auto-encoder. Without any preprocessing process on the feature information, our method can incorporate raw data of node attributes with the topology of the interaction network. Based on a real dataset collected from a public database, the results of experiments conducted on k-fold cross validations illustrate the robustness and effectiveness of the prediction performance of the proposed prediction model. We prove the graph convolution layer as designed in the proposed model able to effectively integrate the input data by filtering the graph with node features. The proposed model is anticipated to yield highly potential lncRNA-miRNA interactions in the scenario that different types of numerical features describing lncRNA or miRNA are provided by users, serving as a useful computational tool.

No abstract

Identification of drug-target interactions (DTIs) is critical for discovering potential target protein candidates for new drugs. However, traditional experimental methods have limitations in discovering DTIs. They are time-consuming, tedious, and expensive, and often suffer from high false-positive rates and false-negative rates. Therefore, using computational methods to predict DTIs has received extensive attention from many researchers in recent years. To address this issue, in this paper, an effective prediction model is presented which is based on the information of drug molecular structure data and protein sequence data. It performs prediction with the following procedures. First, we transform the sequences of each target into a positionspecific scoring matrix (PSSM), such that the features can retain biological evolutionary information. We then use a feature vector of molecular substructure fingerprints to describe the chemical structure information of the drug compounds. Second, the Legendre moments algorithm is used to extract new features from the PSSM. Finally, a classification algorithm called rotation forest is used to perform prediction, we tested its prediction performance on four

No abstract

No abstract

No abstract

No abstract

No abstract